Vincent W. Bloks
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Bile Acid Detergency as Determinant of Liver Pathology in a Humanized Mouse Model of Progressive Familial Intrahepatic Cholestasis Type 3.
Journal: Cellular and molecular gastroenterology and hepatology
Published: October 17, 2025
Bile acid detergency as determinant of liver pathology in a humanized mouse model of progressive familial intrahepatic cholestasis type 3.
Journal: Cellular and molecular gastroenterology and hepatology
Published: October 17, 2025
Farnesoid x Receptor Deficiency Promotes Hepatocytic Injury in Cyp2c70-Deficient Mice With a Human-Like Bile Acid Composition.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 18, 2025
Loss of Early Growth Response Protein 1 in the Liver Leads to Hepatic Lipid Accumulation Driven by an Imbalance Between Fatty Acid β-Oxidation and Oxidative Phosphorylation.
Journal: Gastro hep advances
Published: June 04, 2025
ERICH4 is not involved in the assembly and secretion of intestinal lipoproteins.
Journal: Atherosclerosis
Published: May 20, 2024
Tissue-specific inflammation and insulin sensitivity in subjects with obesity.
Journal: Diabetes research and clinical practice
Published: March 01, 2024
Elevated plasma bile acids coincide with cardiac stress and inflammation in young Cyp2c70-/- mice.
Journal: Pediatric research
Published: January 18, 2024
Changes in bile acid composition are correlated with reduced intestinal cholesterol uptake in intestine-specific WASH-deficient mice.
Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: October 20, 2023
Bile Acid Sequestration via Colesevelam Reduces Bile Acid Hydrophobicity and Improves Liver Pathology in Cyp2c70-/- Mice with a Human-like Bile Acid Composition.
Journal: Biomedicines
Published: August 03, 2023
Gut microbiota depletion aggravates bile acid-induced liver pathology in mice with a human-like bile acid composition.
Journal: Clinical science (London, England : 1979)
Published: July 27, 2023
Treatment of intestinal and liver features in cystic fibrosis mice by the osmotic laxative polyethylene glycol.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: May 22, 2023
Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia.
Journal: Cancer & metabolism
Published: January 25, 2023
Last Updated: 09/26/2026